Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen.
about
Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapyNatural Polyphenols for Prevention and Treatment of CancerSoy and Health Update: Evaluation of the Clinical and Epidemiologic LiteratureAnticancer Efficacy of Polyphenols and Their CombinationsCurcumin as a Modulator of P-Glycoprotein in Cancer: Challenges and PerspectivesRecent progress on nutraceutical research in prostate cancer.The role of GATA2 in lethal prostate cancer aggressiveness.The role of soy in vegetarian dietsMultiple therapeutic and preventive effects of 3,3'-diindolylmethane on cancers including prostate cancer and high grade prostatic intraepithelial neoplasia.Curcumin and cancer: barriers to obtaining a health claim.Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial.The multifaceted role of curcumin in cancer prevention and treatment.Estrogens and prostate cancer: etiology, mediators, prevention, and management.Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial.The role of nutraceuticals in chemoprevention and chemotherapy and their clinical outcomesEpigenetic activities of flavonoids in the prevention and treatment of cancerTherapeutic roles of curcumin: lessons learned from clinical trials.Cancer cell signaling pathways targeted by spice-derived nutraceuticals.Curcumin suppresses NTHi-induced CXCL5 expression via inhibition of positive IKKβ pathway and up-regulation of negative MKP-1 pathway.Future directions in the prevention of prostate cancer.Curcumin, a component of turmeric: from farm to pharmacy.Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkersAdvances in prostate cancer chemoprevention: a translational perspective.Nutrition and prostate cancer: an overview.Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms.Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment.Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges.Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases.Curcumin and Its Role in Chronic Diseases.Curcumin, Piperine, and Capsaicin: A Comparative Study of Spice-Mediated Inhibition of Human Cytochrome P450 Isozyme Activities.Targeting pioneering factor and hormone receptor cooperative pathways to suppress tumor progressionCurcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells.Testosterone augments polyphenol-induced DNA damage response in prostate cancer cell line, LNCaP.Chemoprevention of prostate cancer: soy isoflavones and curcumin.Effects of cyclohexanone analogues of curcumin on growth, apoptosis and NF-κB activity in PC-3 human prostate cancer cells.Modulation of AKR1C2 by Curcumin Decreases Testosterone Production in Prostate Cancer.Nutraceuticals in prostate cancer therapeutic strategies and their neo-adjuvant use in diverse populations
P2860
Q24597964-779B4C71-AEE1-41C8-9D79-BE125E3982ECQ26739022-9F7843C3-076D-4DAC-83CF-5613DF66B2F2Q28071946-64A86ED6-F13A-4893-B842-2A159C13A524Q28076137-2D34605A-FCDC-4A29-AFAE-E6648E5DA2EBQ28078369-1EA8B41D-4F50-45C9-97DD-A6DF7DE0D5ECQ33818800-B8D54166-CA58-4FDE-BF35-900D10FC8F4FQ33848134-50F27124-49FA-4588-95CA-7D016745C585Q34247970-A5F4E6DD-3686-4DBF-9853-9897ACF2119EQ34340728-D2720EAF-DBA2-4B8F-8864-93391B81FF3EQ34478532-810E322D-9F0A-49F6-BFA4-2BED3C474AF6Q34660475-16A3B276-B651-4761-BD06-9126A611F81AQ34667865-63573291-332B-4F11-9F36-A0B705F21DDFQ35196710-67E06CD3-4EBE-45C3-BC32-373207FA6A22Q35358778-2DEFBA0A-D663-49C6-9DBE-71FDEE4DACA3Q35609249-8C624D10-3D5C-45C5-8095-2E82332AA457Q35835175-23D16AA1-6C93-4DEB-89D2-AFE01F36978DQ36502400-DD9F1F01-B0A1-4C4B-A966-BA91A555B05AQ36819371-6E95BCCE-A69B-40A6-A0C9-138BA8234F94Q37188938-F18DDA98-3A50-4FD7-A21B-A8972F42DD83Q37279094-C349DD6A-BE4E-4FE0-9660-6B51DB62F700Q38075863-B59EEB15-205B-436A-9A1D-38B0E77C51D9Q38083084-49741A1F-4A3B-432B-A076-DB5200B6859CQ38107513-0F351F69-F4E8-4843-833B-4CD029EA6C70Q38264784-E375BE72-6C86-4539-9593-CD431669435CQ38668187-94E05D0F-1B34-4E8D-8D7E-E0AD2009EB81Q38790667-3790963B-EFDB-41B7-A68D-9ED4C7C7F0D1Q38818485-0E11D8D3-E9C5-49D3-921C-DE4B1E03C23AQ38957154-D475616A-065A-4BDB-8311-70F534B4C139Q38965184-3B6A4DD2-6803-4728-8574-B9D3168A1446Q39207677-C3FF7B84-C8A2-4B27-8528-E73D34888961Q39410020-3C077C68-27E1-4246-A808-F2F8D4FD6807Q39470443-DB0EFB21-2633-4991-B309-488949ABDA35Q39623453-D739C525-24C0-4808-8569-33B4E1911703Q41466203-9F0733DD-27AE-4ABB-AF75-B756E58A6F1AQ42151185-F52BC095-C740-432E-805C-157B24172D86Q49711327-A6CBBE09-2206-429C-84EF-967F4CC5A519Q57109257-DC4FB82D-D071-49AC-B94B-483B17902125
P2860
Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Combined inhibitory effects of ...... of prostate-specific antigen.
@ast
Combined inhibitory effects of ...... of prostate-specific antigen.
@en
Combined inhibitory effects of ...... of prostate-specific antigen.
@nl
type
label
Combined inhibitory effects of ...... of prostate-specific antigen.
@ast
Combined inhibitory effects of ...... of prostate-specific antigen.
@en
Combined inhibitory effects of ...... of prostate-specific antigen.
@nl
prefLabel
Combined inhibitory effects of ...... of prostate-specific antigen.
@ast
Combined inhibitory effects of ...... of prostate-specific antigen.
@en
Combined inhibitory effects of ...... of prostate-specific antigen.
@nl
P2093
P356
P1433
P1476
Combined inhibitory effects of ...... of prostate-specific antigen.
@en
P2093
Hiroko Masuda
Hisamitsu Ide
Kentaro Sakamaki
Koujiro Nishio
Satoru Muto
Shigeo Horie
Shino Tokiwa
Shuji Isotani
Takanori Hama
P2860
P304
P356
10.1002/PROS.21147
P577
2010-07-01T00:00:00Z